Bellevue Group AG AKRO Holdings History
Bellevue Group AG's Akero Therapeutics Inc Holding Summary
As of 2025-03-31, Bellevue Group AG held 1.25 Mil shares of Akero Therapeutics Inc(AKRO), totaling $50.63 Mil. This investment constitutes 1.13% of their stock portfolio, and Bellevue Group AG now holds 1.57% of the outstanding Akero Therapeutics Inc(AKRO) stock.
The initial trade took place in 2022Q3. And since then Bellevue Group AG has made 4 purchases of AKRO, at an average price of $41.52, for a total of 1.29 Mil shares. In addition, there have been 3 sales at an average price of $30.44 for 43,650.00 shares. Based on historical transaction data and AKRO's current price of $52.08, Bellevue Group AG's estimated gain on his AKRO holdings is $12.72 Mil, reflecting a 23.67% gain to date.
Bellevue Group AG AKRO ($52.08) Holding Chart
Bellevue Group AG AKRO ($52.08) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
